Stéphane Bancel

Fierce Pharma

Vaccine makers facing increased volatility, uncertainty at FDA

The FDA's decision to not review Moderna's flu vaccine application is another indication of the volatility and unpredictability of the U.S. regulator.

Kevin Dunleavy Feb 13, 2026 11:12am

Moderna sprints toward RSV podium behind GSK, Pfizer

Jan 4, 2023 3:37pm

Moderna CEO: Mpox vaccine development is not a high priority

Jan 4, 2023 9:49am

Moderna's Bancel has 'never been as busy' amid M&A talks

May 4, 2022 11:19am

Moderna's CMO Zaks quits for 'next leg of his career'

Feb 25, 2021 7:23am

Moderna finalizes design of phase 3 COVID-19 vaccine trial

Jun 11, 2020 8:45am